Drug · DIN 02059770
AREDIA
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 30, 2001; first marketed December 31, 1994.
- Drug Identification Number (DIN)
- 02059770
- Company (DIN owner)
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Pamidronic acid M05BA03
- Class
- Human
- Record last updated
- June 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PAMIDRONATE DISODIUM | 60 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 20, 1997: NOC 4008New Drug Submission (NDS)